Cargando…

Primary mediastinal synovial sarcomas

Synovial sarcoma is a malignant mesenchymal neoplasm that accounts for approximately 10% of all soft tissue sarcomas. These tumors most commonly occur in the extremities of young adults but are not restricted to this site and can arise in virtually any organ system. Synovial sarcomas originating in...

Descripción completa

Detalles Bibliográficos
Autores principales: Syred, Katherine, Weissferdt, Annikka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794274/
https://www.ncbi.nlm.nih.gov/pubmed/35118281
http://dx.doi.org/10.21037/med-20-19
_version_ 1784640792657133568
author Syred, Katherine
Weissferdt, Annikka
author_facet Syred, Katherine
Weissferdt, Annikka
author_sort Syred, Katherine
collection PubMed
description Synovial sarcoma is a malignant mesenchymal neoplasm that accounts for approximately 10% of all soft tissue sarcomas. These tumors most commonly occur in the extremities of young adults but are not restricted to this site and can arise in virtually any organ system. Synovial sarcomas originating in the mediastinum are exceptionally rare and are often mistaken for other, more common neoplasms in this location, especially since there are no specific imaging characteristics or clinical manifestations. Contrary to synovial sarcomas of the extremities, mediastinal tumors more commonly affect male patients. Histologically, these tumors can be divided into monophasic, biphasic and poorly differentiated variants, further complicating the diagnostic process. Recent advances in immunohistochemical and molecular techniques have provided useful tools to confirm the diagnosis and distinguish these tumors from other mediastinal neoplasms. The treatment of mediastinal synovial sarcomas often requires multimodal therapy, including surgery, chemotherapy and radiation. Despite this, the prognosis for synovial sarcomas in this location appears to be worse than for their analogues in the soft tissue, likely related to the often large size of the lesions and close proximity to critical anatomic structures making complete surgical resection difficult to achieve. This review summarizes the clinicopathological, immunohistochemical and molecular characteristics of these rare neoplasms.
format Online
Article
Text
id pubmed-8794274
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87942742022-02-02 Primary mediastinal synovial sarcomas Syred, Katherine Weissferdt, Annikka Mediastinum Review Article Synovial sarcoma is a malignant mesenchymal neoplasm that accounts for approximately 10% of all soft tissue sarcomas. These tumors most commonly occur in the extremities of young adults but are not restricted to this site and can arise in virtually any organ system. Synovial sarcomas originating in the mediastinum are exceptionally rare and are often mistaken for other, more common neoplasms in this location, especially since there are no specific imaging characteristics or clinical manifestations. Contrary to synovial sarcomas of the extremities, mediastinal tumors more commonly affect male patients. Histologically, these tumors can be divided into monophasic, biphasic and poorly differentiated variants, further complicating the diagnostic process. Recent advances in immunohistochemical and molecular techniques have provided useful tools to confirm the diagnosis and distinguish these tumors from other mediastinal neoplasms. The treatment of mediastinal synovial sarcomas often requires multimodal therapy, including surgery, chemotherapy and radiation. Despite this, the prognosis for synovial sarcomas in this location appears to be worse than for their analogues in the soft tissue, likely related to the often large size of the lesions and close proximity to critical anatomic structures making complete surgical resection difficult to achieve. This review summarizes the clinicopathological, immunohistochemical and molecular characteristics of these rare neoplasms. AME Publishing Company 2020-06-30 /pmc/articles/PMC8794274/ /pubmed/35118281 http://dx.doi.org/10.21037/med-20-19 Text en 2020 Mediastinum. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Review Article
Syred, Katherine
Weissferdt, Annikka
Primary mediastinal synovial sarcomas
title Primary mediastinal synovial sarcomas
title_full Primary mediastinal synovial sarcomas
title_fullStr Primary mediastinal synovial sarcomas
title_full_unstemmed Primary mediastinal synovial sarcomas
title_short Primary mediastinal synovial sarcomas
title_sort primary mediastinal synovial sarcomas
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794274/
https://www.ncbi.nlm.nih.gov/pubmed/35118281
http://dx.doi.org/10.21037/med-20-19
work_keys_str_mv AT syredkatherine primarymediastinalsynovialsarcomas
AT weissferdtannikka primarymediastinalsynovialsarcomas